What should be done for a suddenly enlarged, tender, round, non-erythematous, firm, and movable sternal mass?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of a Suddenly Enlarged, Tender Sternal Mass

A suddenly enlarged, tender, round, non-erythematous, firm, and movable sternal mass in a young patient (under 4 years old) most likely represents self-limiting sternal tumor of childhood (SELSTOC) and should be managed with close observation and serial physical examinations over 1-6 months, avoiding invasive procedures unless the mass fails to regress. 1

Initial Clinical Assessment

Age-Based Differential Diagnosis

For children under 4 years of age:

  • The sudden increase in size with tenderness strongly suggests SELSTOC, a benign aseptic inflammatory condition that presents as a rapidly growing sternal mass in young children (median age 16 months, range 7-50 months) 1
  • SELSTOC characteristically presents as a solid, pre-sternal or para-sternal mass with median diameter of 3 cm (range 1-4.5 cm), often with local pain and sometimes with red/blue skin discoloration 1
  • The movable, firm nature without erythema fits the typical presentation of SELSTOC 1

For adults or older patients:

  • Primary malignant tumors (chondrosarcoma most common, followed by osteosarcoma) typically present as a mass, with half of patients also experiencing sternal pain 2
  • Metastatic disease should be considered, particularly in patients with known malignancy history 3

Recommended Management Algorithm

For Suspected SELSTOC (Young Children)

Adopt a wait-and-see approach with close follow-up:

  • Perform serial physical examinations weekly for the first month 1
  • The mass should decrease in size within 1 month and completely disappear on physical examination within 6 months 1
  • Antibiotics are not necessary, as tumors resolve equally well with or without antibiotic treatment 1

Imaging if performed (though not mandatory for typical presentations):

  • If imaging is obtained, expect to see dumbbell-shaped lesions extending behind the sternal bone, involving cartilage, with increased distance between ossification centers 1
  • CT may show widening of the synchondrosis between sternal elements 4

Avoid invasive procedures initially:

  • Histopathology, when performed, typically shows nonspecific chronic or acute inflammation 1
  • Laboratory infection parameters are usually not elevated or only slightly raised, and microbiologic cultures are negative 1
  • Invasive diagnostic interventions and unnecessary treatment should be prevented by this conservative approach 1

For Adults or Atypical Presentations

Immediate imaging is required:

  • Obtain CT of the chest to characterize the mass and assess for pulmonary metastases 5
  • MRI provides the most accurate information for diagnosis and surgical planning for soft tissue tumors 5
  • Look for irregular, multilobulated, heterogeneously enhancing masses with intralesional calcifications, which suggest sarcoma 5

Tissue diagnosis:

  • Percutaneous core needle biopsy is the standard approach, with multiple cores taken under image guidance 5
  • Plan the biopsy tract so it can be safely removed during definitive surgery 5
  • Fine needle aspiration is not recommended as a primary diagnostic modality 5

Specialist referral:

  • Refer to a specialist sarcoma multidisciplinary team (MDT) for any suspicious mass in adults 5
  • Referral should occur within 2 weeks via a suspected cancer pathway 5

Key Clinical Pitfalls to Avoid

Do not perform invasive biopsies in young children with typical SELSTOC presentation:

  • The characteristic rapid growth, tenderness, and age profile (under 4 years) should prompt observation rather than immediate biopsy 1
  • Unnecessary invasive procedures expose children to procedural risks without benefit 1

Do not delay specialist referral in adults:

  • Primary sternal sarcomas, though uncommon, are potentially curable by wide surgical excision when diagnosed early 2
  • Chondrosarcomas have an 80% 5-year survival with resection, while high-grade sarcomas have only 7% survival, emphasizing the importance of early diagnosis and treatment 2

Do not rely solely on clinical examination in adults:

  • Half of patients with malignant sternal tumors present with mass alone, without pain, making clinical assessment insufficient 2
  • Imaging is essential to characterize the lesion and plan appropriate management 5

Indications for Urgent Intervention

Proceed to immediate imaging and biopsy if:

  • The patient is an adult or older child (over 4 years) 1, 2
  • The mass fails to decrease in size within 1 month in a young child 1
  • There are concerning features such as fixed (non-movable) mass, skin ulceration, or systemic symptoms suggesting malignancy 5
  • There is known history of malignancy, as metastatic disease to the sternum occurs and requires different management 3

References

Research

Self-limiting sternal tumors of childhood (SELSTOC).

Pediatric blood & cancer, 2010

Research

Predictors of survival in malignant tumors of the sternum.

The Journal of thoracic and cardiovascular surgery, 1996

Research

[Metastatic sternal mass].

Revue medicale de Bruxelles, 2006

Research

A case of self-limiting sternal tumor of childhood.

Radiology case reports, 2021

Guideline

Management Approach for Suspicious Soft Tissue Mass in the Thigh

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.